These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Necrotizing enterocolitis and gastrointestinal complications after indomethacin therapy and surgical ligation in premature infants with patent ductus arteriosus. O'Donovan DJ; Baetiong A; Adams K; Chen A; Smith EO; Adams JM; Weisman LE J Perinatol; 2003 Jun; 23(4):286-90. PubMed ID: 12774134 [TBL] [Abstract][Full Text] [Related]
27. Fetal reversed constrictive effect of indomethacin and postnatal delayed closure of the ductus arteriosus following administration of transplacental magnesium sulfate in rats. Toyoshima K; Momma K; Nakanishi T Neonatology; 2009; 96(2):125-31. PubMed ID: 19279396 [TBL] [Abstract][Full Text] [Related]
28. Vaginal versus oral indomethacin in a rabbit model for non-infection-mediated preterm birth: an alternate tocolytic approach. Fortson W; Beharry KD; Nageotte S; Sills JH; Stavitsky Y; Asrat T; Modanlou HD Am J Obstet Gynecol; 2006 Oct; 195(4):1058-64. PubMed ID: 17000239 [TBL] [Abstract][Full Text] [Related]
29. Indomethacin and fetal ductus arteriosus: complete closure after cessation of prolonged therapeutic course. Ben-David Y; Hallak M; Rotschild A; Sorokin Y; Auslender R; Abramovici H Fetal Diagn Ther; 1996; 11(5):341-4. PubMed ID: 8894629 [TBL] [Abstract][Full Text] [Related]
33. The effect of indomethacin tocolysis on fetal ductus arteriosus constriction with advancing gestational age. Vermillion ST; Scardo JA; Lashus AG; Wiles HB Am J Obstet Gynecol; 1997 Aug; 177(2):256-9; discussion 259-61. PubMed ID: 9290437 [TBL] [Abstract][Full Text] [Related]
34. Treatment strategies to prevent or close a patent ductus arteriosus in preterm infants and outcomes. Laughon M; Bose C; Clark R J Perinatol; 2007 Mar; 27(3):164-70. PubMed ID: 17251985 [TBL] [Abstract][Full Text] [Related]
35. Prenatal administration of indomethacin as a tocolytic agent: effect on neonatal renal function. Wurtzel D Obstet Gynecol; 1990 Oct; 76(4):689-92. PubMed ID: 2216206 [TBL] [Abstract][Full Text] [Related]
36. Safety and efficacy of long-term tocolysis with indomethacin. Gerson A; Abbasi S; Johnson A; Kalchbrenner M; Ashmead G; Bolognese R Am J Perinatol; 1990 Jan; 7(1):71-4. PubMed ID: 2294913 [TBL] [Abstract][Full Text] [Related]
37. Good fetal outcome following prolonged indomethacin induced anhydramnios. Case report. Shen O; Rabinowitz R; Lavie O; Aboulafia Y; Diamant YZ J Perinat Med; 1995; 23(3):233-6. PubMed ID: 8568616 [TBL] [Abstract][Full Text] [Related]
38. Patent ductus arteriosus after prolonged treatment with indomethacin during pregnancy: case report. Atad J; Lissak A; Rofe A; Abramovici H Int J Gynaecol Obstet; 1987 Feb; 25(1):73-6. PubMed ID: 2883050 [TBL] [Abstract][Full Text] [Related]
39. Fetal and neonatal effects of indomethacin used as a tocolytic agent. Dudley DK; Hardie MJ Am J Obstet Gynecol; 1985 Jan; 151(2):181-4. PubMed ID: 3970083 [TBL] [Abstract][Full Text] [Related]
40. Premature onset of labor, neonatal patent ductus arteriosus, and prostaglandin synthetase antagonists--a rat model of a human problem. Altshuler G; Krous HF; Altmiller DH; Sharpe GL Am J Obstet Gynecol; 1979 Sep; 135(2):261-5. PubMed ID: 112867 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]